Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof

Details for Australian Patent Application No. 2004249431 (hide)

Owner Centre National de la Recherche Scientifique Institut Pasteur

Inventors Sebo, Peter; Osicka, Radim; Leclerc, Claude; Ladant, Daniel; Loucka, Jirina; Bauche, Cecile; El-Azami El-Idrissi, Mohammed

Agent Cullens

Pub. Number AU-B-2004249431

PCT Pub. Number WO2004/113372

Priority 03291486.3 18.06.03 EP

Filing date 18 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 5 November 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 15/60 (2006.01) Mutation or genetic engineering - Lyases (4)

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/113372 Priority application(s): WO2004/113372

5 November 2009 Application Accepted

  Published as AU-B-2004249431

4 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249436-A process for the preparation of a pigment comprising a core material and at least one dielectric layer

2004249430-Novel compounds that modulate PPARgamma type receptors, and use thereof in cosmetic or pharmaceutical compositions